Organovo Holdings, Inc. Company

At Organovo, we design and create functional human tissues using our proprietary three-dimensional bioprinting technology. Our goal is to build living human tissues that are proven to function like native tissues. Organovo is focused on delivering breakthrough three-dimensional biology capabilities to create tissue on demand for research and surgical applications. As the first company with a three-dimensional tissue technology that works across tissue types, they are meeting the promise of regenerative medicine to fill unmet medical needs.
Industry:
Regenerative Medicine
Investment Stage:
N/A
Technology:
Regenerative Medicine - other
Headquarters:
San Diego
Founded Date:
2007
Investor Type:
N/A
Funding Status:
IPO
Number Of Exists:
N/A
Employee Number:
Undisclosed